Equipment and technology
Top centres are equipped with negative-pressure isolation, advanced microbiology/PCR labs and clinical-trial units; infrastructure is broadly comparable with international standards.

Explore hospitals in our directory that appear in Fudan University’s 2023 top-ten specialty rankings related to this health area. Each card identifies the specialty and position that connects the hospital to this category.
If you are researching infectious disease care in China or infectious disease treatment in China for yourself or a family member, the practical question is simple: how does care here compare with the best centres abroad? Below is a grounded, numbers-based comparison written for international patients.
China’s leading infectious-disease institution — Huashan Hospital of Fudan University (its infection department has ranked #1 in Fudan for 11 consecutive years and is the host of the National Center for Infectious Diseases, designated in 2021) — sits in the country’s first tier, with Beijing Ditan and You’an hospitals also strong in HIV and hepatitis. As an international benchmark, Johns Hopkins Hospital — top-ranked in US infectious disease by U.S. News — remains a global reference.
Top centres are equipped with negative-pressure isolation, advanced microbiology/PCR labs and clinical-trial units; infrastructure is broadly comparable with international standards.
China carries a large infectious-disease burden — about 80 million people live with chronic hepatitis B — so screening, antiviral and HIV care volumes at major centres are very large. Complex infections, resistant TB and emerging-infectious disease response are routine at the top centres. Relative gaps remain in the very newest antimicrobials and in clinical-trial infrastructure versus Johns Hopkins and similar institutions.
Standard antivirals, antibiotics and HIV therapy are widely available and inexpensive; the newest antimicrobials can reach China later than the US/EU — verify per drug.
China has a large infectious-disease workforce with many clinicians trained internationally; research output is growing. International leaders still set more original research, but the gap is narrowing.
| Metric | China | Global benchmark | Read |
|---|---|---|---|
| Chronic hepatitis B carriers (China) | ~80 million | US far smaller | Among the world’s largest |
| Infectious-disease capacity | National Center at Huashan; large screening volumes | Johns Hopkins sets the standard | Comparable |
China has about 80 million people living with chronic hepatitis B (research published in The Lancet Regional Health, 2024).
Infectious-disease care in China typically costs a fraction of US/EU prices — a core reason international patients consider infectious disease treatment in China.
At most top centres, waits for consultation and common treatment are shorter than in many public systems; international patient departments usually offer expedited booking.
Major centres run international clinics with English-speaking coordinators and self-pay / commercial insurance handling — directly relevant if you are weighing best hospitals for infection in China.
Yes. Major infectious-disease centres regularly treat international patients, and many have dedicated international departments. Suitability is decided case by case by the treating team.
Yes. American patients come to China for planned hepatitis B/HIV evaluation and treatment, often for lower cost and shorter waits. Bring your records and allow time for translation and coordination.
The largest tertiary centres and their international departments provide English-speaking doctors and coordinators. For other settings, a medical interpreter or coordinator such as Wellward China is recommended.
Through a hospital international clinic, a local coordinator, or by contacting a service like Wellward China with your records and goals. Appointments at top centres can often be arranged faster than in many public systems.
A comparable course of care is typically a fraction of US prices in China, largely because of lower hospital and staffing costs. Exact figures vary by condition and hospital — request a written quote per case.
US prices reflect hospital charges, specialist fees, insurance administration and high drug costs. That gap is exactly why some international patients explore infection treatment in China as a pragmatic alternative.
For common, high-prevalence infectious needs — hepatitis, HIV, resistant infection — China’s top centres are highly competitive on cost, access and scale. For the very newest antimicrobials, China can be an efficient, pragmatic option, ideally combined with an international second opinion.
Infectious Diseases is the primary ranking link. Tuberculosis and Respiratory Medicine are supplementary where infection type or location makes them relevant. The Chinese labels below follow the names shown in the Fudan specialty rankings.
Direct primary association for infectious conditions and infection-related evaluation.
May be relevant for suspected or diagnosed tuberculosis.
May be relevant when an infection affects the lungs or breathing.
Cards merge hospitals that appear in more than one relevant specialty list. Each badge keeps its specialty and rank visible; none of the positions is a cross-specialty overall ranking.
The relevant specialty depends on the patient’s records, symptoms and goals. Browse the hospital directory or contact us to discuss practical information and coordination options.
Share your question, relevant records and intended travel timing. We can explain possible coordination steps.
Talk to a Concierge →